microRNA-210 (miR-210) has generally been reported to be associated with cell survival under hypoxia. However, there are few data regarding the role of miR-210 in the survival of mesenchymal stem cells (MSCs) under oxidative stress conditions. Thus, we sought to investigate whether miR-210 over-expression could protect MSCs against oxidative stress injury and what the primary mechanisms involved are. The results showed that over-expression of miR-210 significantly reduced the apoptosis of MSCs under oxidative stress, accompanied by obvious increases in cell viability and superoxide dismutase activity and remarkable decreases in malonaldehyde content and reactive oxygen species production, resulting in a noticeable reduction of apoptotic indices when compared with the control. Moreover, the above beneficial effects of miR-210 could be significantly reduced by c-Met pathway repression. Collectively, these results showed that miR-210 over-expression improved MSC survival under oxidative stress through antioxidation and c-Met pathway activation, indicating the potential development of a novel approach to enhance the efficacy of MSC-based therapy for injured myocardium.
Mesenchymal stem cells (MSCs) derived from bone marrow have become therapeutically important agents for injured myocardium repair because of their ability to differentiate into various cell types and to secrete protective factors [1] . However, the poor survival of transplanted MSCs greatly hampers their therapeutic efficacy [2, 3] ; this is mainly because the microenvironments that transplanted MSCs are exposed to often have various features that promote cell apoptosis, including oxidative stress (such as superoxide anions and hydrogen peroxide), hypoxia and inflammatory reactions [4] . An increasing number of studies have mentioned that excessive accumulation of reactive oxygen species (ROS) constantly pose a direct threat to cells via damage of the cell membrane, protein and DNA, leading to an alteration or loss of cellular functions [5, 6] . Therefore, a strategy that protects MSCs against oxidative stress-induced injury might help to provide a cell-based treatment for heart disease.
microRNAs (miRNAs, miRs), through a combination of translational blockade and/or mRNA degradation, have been widely reported to possess the potential to regulate pathological and physiological processes [7] , including proliferation, differentiation, death, metabolism and oxidative stress. It is currently believed that thousands of classic (protein-encoding) genes are controlled via such mechanisms; furthermore, it has been shown that some miRNAs tend to be associated with some special functional regulatory mechanisms [8] , such as miR-146a for inflammatory response [9] and miR-126 for angiogenesis modulation [10] .
In particular, miR-210 has been previously reported to be involved in oxidative stress and apoptotic defense [11] ; for example, the blockade of miR-210 in myoblasts greatly increased myotube sensitivity to oxidative stress and mitochondrial dysfunction [12] . However, whether miR-210 plays a role in the apoptosis of MSCs exposed to oxidative stress and, if so, the underlying mechanism requires investigation. Therefore, we compared the viability of MSCs overexpressing miR-210 with the control, and we examined the signal pathways that were potentially involved. Because the c-Met pathway is a key mechanism associated with cell apoptosis [13] , we focused on the change of c-Met phosphorylation during this process. Additionally, we examined the activity of superoxide dismutase (SOD) [14] , the level of malonaldehyde (MDA) [15] , and the accumulation of ROS [16] , which are reliable indicators for cellular oxidative stress. Hydrogen peroxide (H 2 O 2 ), widely used as an oxidant in vitro, was applied to develop a cellular model of oxidative stress damage.
Materials and methods
All animal treatments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals, published by the National Academy Press (NIH Publication No. 85-23, Revised 1996) . The studies were approved by the Animal Care and Use Committee of Zhongshan Hospital, Fudan University.
Isolation and culture of MSCs
MSCs were derived from 4-week-old Sprague-Dawley (SD) rats according to the methods described in our previous study [17] . Briefly, the bone marrow in femurs and tibias was flushed with Dulbecco's modified Eagle's medium (DMEM; GIBCO, USA), 10% fetal bovine serum (FBS; GIBCO) and penicillin/streptomycin. After incubation at 37°C in an atmosphere of 5% CO 2 , the culture medium of bone marrow solution was changed every 34 d, and the spindleshaped, adherent MSCs were isolated and expanded. Passage 4 MSCs were used for subsequent experiments. (CalBiochem, USA) adopted in these experiments was determined from pilot studies (data not shown) and based on similar methods used in the literature [18] .
In vitro

MSC viability assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, USA) assay was used to detect the viability of MSCs, which were treated with different concentrations of H 2 O 2 in prescribed concentrations as follows: 0, 100, 200, 400 and 1000 μmol L 1 at 37°C and 5% CO 2 for 24 h and were then further cultured with 10 μL of 5 μg mL 1 MTT for 4 h. Dimethyl sulfoxide (DMSO; Sigma) was added to solubilize the formazan crystals after the supernatant was discarded. After another 4-h incubation, the cell density was analyzed using an enzyme-linked immunosorbent assay reader (spectrophotometer) at 570 nm. Each group consisted of three samples, and the reading of each was performed in triplicate to produce a mean for viability analysis.
Caspase-3 activity assay
Caspase-3 activity was investigated in MSCs lysates (200 μg) using a Caspase-3/CPP32 Fluorometric Assay kit (BioVision, USA) according to the manufacturer's instructions. Briefly, the fluorogenic CPP32/caspase-3 substrate was labeled with the fluorochrome 7-amino-4-methyl coumarin, and then the amount of fluorescence produced upon cleavage was proportional to the amount of caspase-3 activity present in the sample.
miR-210 transfection
AgomiR-210 (Ribobio, Guangzhou, China), labeled with the fluorophore 6′-FAM, was diluted to a final concentration as prescribed. According to the manufacturer's instruc-tions, MSCs were seeded into 24-well plates and were then transfected with agomiR-210 or the agomiR-scramble control at the indicated concentration (Ribobio), using Lipofectamine 2000 as the vehicle (Invitrogen, USA). The efficiency of transfection was determined by both quantitative-PCR and fluorescent detection.
Quantitative polymerase chain reaction (PCR)
microRNA was extracted from cultured cells using a mirVanaTM miRNA Isolation Kit (Ambion, USA), and complementary DNA was reverse-transcribed using a TaqMan microRNA Reverse Transcription Kit (ABI, 4366596) according to the manufacturer's protocols. The housekeeping gene miR-16 was served as internal control and the specific probes of miR-210 and miR-16 were gained from TaqMan microRNA assay kits (ABI, 4373089; ABI, 4373121). Quantitative PCR analysis was performed using TaqMan Universal PCR Master Mix (ABI, 4324018) and a 7300 real-time PCR system (Applied Biosystems, USA) according to a PCR protocol (95°C for 10 min, then 40 cycles of 95°C for 15 s, and 60°C for 1 min). All the results were subjected to melting curve analysis, and the relative gene expressions of miR-210 were analyzed using 2 C t method.
All reactions were independently performed in triplicate.
Hoechst 33342 staining
To identify the cells, apoptosis, nuclear DNA in treated cells contained in 24-well plates was viewed by staining with Hoechst 33342, a DNA-specific dye, at a final concentration of 5 mg mL 1 . Five fields at high magnification (×200) were randomly chosen, and cells were immediately observed with filters for blue fluorescence, in which apoptosis index was calculated as a percentage of cells with strong blue fluorescent-nuclei to total cells.
Determination of SOD and MDA levels
SOD activities and MDA contents in the supernatant of cultured MSCs were measured by commercially purchased kits using colorimetric assay from Nanjing Jancheng Bioengineering Institute according to the manufacturer's instructions.
Western blot analysis
MSCs from each group were lysed using RIPA buffer containing 1 mmol L 1 phenylmethanesulfonylfluoride on ice for 30 min according to the methods described in the previous studies. Briefly, the lysates were centrifuged at 4°C and 15000 r min 1 for 30 min, and then the protein component was isolated to separate by 12% SDS-PAGE followed by transfer to polyvinylidene fluoride membranes (Millipore, USA). The membranes were incubated overnight at 4°C
with anti-phospho-c-Met or anti-c-Met (Cell Signaling, USA), and then were washed for 30 min. After the membranes were incubated with a secondary antibody conjugated to horseradish peroxidase-conjugated IgG (Jackson, USA) for 1 h, protein expression was determined using an enhanced chemiluminescence system and quantified by densitometry (Image System; Bio-Rad, USA).
TUNEL (terminal dexynucleotidyl transferasemediated dUTP nick end labeling) assay
TUNEL was performed using the In Situ Cell Death Detection Kit (Roche, Switzerland) according to the manufacturer's protocols. In brief, MSCs were fixed in 3.7% buffered formaldehyde, pretreated with 3.0% H 2 O 2 and exposed to TdT enzyme at 37°C for 1 h. After the MSCs were incubated with digoxigenin-conjugated nucleotide substrate at 37°C for 30 min, nuclei exhibiting DNA fragmentation were identified after staining with 3,3-diamino benzidine (DAB) for 5 min. The MSCs were counterstained with hematoxylin, and the percentage of labeled cells was calculated as the apoptosis index in five fields at high magnification (×200), which were chosen randomly.
Measurement of ROS
The generation of intracellular ROS was evaluated using an oxidation-sensitive fluorescent dihydroethidium (DHE) probe (Vigorous, China), which can cross cell membranes and is rapidly oxidized in the presence of ROS, resulting in the formation of a highly fluorescent form of oxidative ethidium.
In this assay, MSCs were incubated with 10 μmol L 1 DHE in phenol-red-free MEM medium (Invitrogen) at 37°C in the dark. After 15 min exposure, the cells were rinsed, and the medium was replaced. The fluorescence level, as an indicator of ROS accumulation, was observed using fluorescence microscopy.
Statistical analysis
Statistical analysis was performed using SPSS version 16.0. All data are shown as the mean±standard error (SE). Differences between groups were analyzed using Student's t-test, while comparisons between more than two groups were performed using one-way analysis of variance (ANOVA) with Bonferroni's correction. P<0.05 were considered to be significant.
Results
H 2 O 2 induced MSC apoptosis in a concentration-dependent manner
The MTT and caspase-3 activity assays consistently showed that H 2 O 2 , with a culture duration of 4 h, impaired the viability of MSCs in a dose-dependent manner over the investigated concentration range (Figure 1 
miR-210 over-expression protected MSCs against H 2 O 2 -induced apoptosis
Quantitative PCR was used to determine the efficiency of agomiR-210 transfection, and miR-210 was shown to be up-regulated when the concentration of agomiR-210 was over 50 nmol L 1 (Figure 2A) . Meanwhile, there were no significant differences in cell viability when the concentration of agomiR-210 was under 200 nmol L 1 ( Figure 2B and (Figure 3 ).
miR-210 over-expression enhances MSC survival through antioxidation
The Figure 4B ). Meanwhile, there were no significant differences in either the SOD activities or the MDA levels of the MSCs and MSCs miR-210 groups (both P>0.05).
miR-210 over-expression attenuates the c-Met activity repression induced by H 2 O 2
Western blot analysis was used to assess the changes in activity of the c-Met pathway. The results indicated that transfection of the agomiR-scramble did not significantly affect the phosphorylation of c-Met (P>0.05), while over-expression of miR-210 significantly up-regulated the activity of the c-Met pathway (P<0.05 Figure 5A ). 
The c-Met pathway mediates the protective effect of miR-210 on MSC apoptosis induced by H 2 O 2
Western blot analysis suggested that SU11274 (10 μmol L 
Discussion
Transplantation of mesenchymal stem cells has been reported to be an attractive approach for cardiovascular therapy because of the capacity of these cells to facilitate myocardial repair in models of cardiac injury, such as myocardial infarction [1]. However, this approach has been shown to be limited because even when 6×10 7 MSCs were implanted in infarcted porcine hearts, only a slight improvement of LVEF occurred [2] . The poor viability of MSCs exposed to oxidative stress, hypoxia and inflammatory attack greatly restricted the efficacy of cell-based treatment [17] , which prompted the exploration of a series of strategies to prevent peri-transplantation graft cell death. microRNAs (miRNAs) regulate gene expression at a post-transcriptional level by inhibiting mRNA translation or promoting mRNA degradation [19] and are increasingly reported to play major roles in the death or apoptosis of cells [11, 12] . Multiple studies have shown that miR-210 is closely involved with hypoxic response and oxidative stress regulation in cancer cells, and high levels of miR-210 have been linked to an adverse prognosis in cancer patients [20, 21] . A wide spectrum of miR-210 targets have been shown to be involved in mitochondrial metabolism, oxidative stress and cell survival, which broadly affect a variety of pathological settings, such as cancer and ischemic disorders [22] . However, whether miR-210 can influence MSC survival in oxidative stress conditions and the underlying molecular mechanism are not yet fully understood.
Therefore, we attempted to clarify whether overexpression of miR-210 in MSCs could enhance cell viability and reduce oxidative stress-induced apoptosis. In the present study, we showed that miR-210 over-expression in MSCs suppressed the MDA level and increased SDA activity, thus protecting MSCs from H 2 O 2 -induced apoptosis in vitro. The mechanism involved the activation of c-Met, an upstream factor of the PI3K/Akt pathway, which was regarded as pivotal in controlling cell survival. We also demonstrated that inhibition of the c-Met pathway reversed the beneficial effect of miR-210, indicating that c-Met activation was the key mechanism for the protective role of miR-210 in MSC survival under oxidative stress, which down-regulated the phosphorylation of c-Met. Additionally, we showed that suppressing the c-Met pathway abolished the restraining function of miR-210 on ROS production induced by H 2 O 2 , suggesting that c-Met phosphorylation occurs upstream of ROS generation. Based on previous studies showing that excessive accumulation of ROS has been shown to damage stem cells through JNK-and caspase-mediated mechanisms [23] , it could be suggested that over-expression of miR-210 in MSCs decreased intracellular oxidative reactions through the activation of the c-Met pathway, thus leading to an obvious improvement of cell viability under oxidative stress. In stem cells, miR-210 might play a critical function that links apoptosis signals to the oxidative stress microenvironment, which is the vital finding in our study and was consistently shown by previous reports [24, 25] . Favaro et al. [21] showed that ROS accumulation could be alleviated with antimiR-210 treatment in cancer cell lines. Furthermore, Chan et al. [20] demonstrated that, in normal endothelial cells, they could not detect any significant change in ROS generation after exposure to hypoxia, which increased when miR-210 was down-regulated. Elucidating the role of miR-210 in MSC apoptosis induced by oxidative stress may lead to novel therapeutic approaches that enhance the efficacy of MSC-based treatment for injured myocardium, which was the most clinically significant conclusion from our results.
The novelty of the present study is that we explored a probable modification of MSCs that improves cell viability under oxidative stress. Identifying the diverse signatures and functions of miRNAs in MSC pathophysiology may help fully elucidate the precise modulatory mechanism when pro-apoptotic factors are present; a clear understanding of the role of miR-210 in this process may be a step in this direction.
In the current study, we did not further investigate, in vivo, whether the survival of MSCs over-expressing miR-210 could be enhanced in the infarcted myocardium. This will be the subject of future research, along with an observation of other underlying effects of miR-210 on MSCs (such as cell proliferation, migration and secretion), which may be critical in restoring cardiac function.
In summary, we demonstrated that miR-210 overexpression protected against H 2 O 2 -induced apoptosis in MSCs by antioxidation and the up-regulation of the c-Met pathway. These discoveries provide an experimental basis for the development of MSC-based treatment for ischemic heart disease and for thorough clarification of MSC survival regulation from a miRNA-modulation perspective. 
